Cargando…

Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice

OBJECTIVE: Activation of the nuclear hormone receptor peroxisome proliferator–activated receptor (PPAR)-δ has been shown to improve insulin resistance, adiposity, and plasma HDL levels. Several studies have reported that activation of PPARδ is atheroprotective; however, the role of PPARδ in renal fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsushita, Yuichi, Ogawa, Daisuke, Wada, Jun, Yamamoto, Noriko, Shikata, Kenichi, Sato, Chikage, Tachibana, Hiromi, Toyota, Noriko, Makino, Hirofumi
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046857/ https://www.ncbi.nlm.nih.gov/pubmed/21270242 http://dx.doi.org/10.2337/db10-1361

Ejemplares similares

Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage: Anti-inflammatory Effect of Cholecystokinin
por: Miyamoto, Satoshi, et al.
Publicado: (2012)

Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
por: Kitada, Munehiro, et al.
Publicado: (2011)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
por: Furuichi, Kengo, et al.
Publicado: (2020)

Oral Peroxisome Proliferator–Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes
por: Teo, Calesta Hui Yi, et al.
Publicado: (2023)

Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis
por: Caglayan, Evren, et al.
Publicado: (2008)

PPARδ Activation Protects Endothelial Function in Diabetic Mice
por: Tian, Xiao Yu, et al.
Publicado: (2012)

Increased Inner Ear Susceptibility to Noise Injury in Mice With Streptozotocin-Induced Diabetes
por: Fujita, Takeshi, et al.
Publicado: (2012)

Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013)

Catalase Deficiency Accelerates Diabetic Renal Injury Through Peroxisomal Dysfunction
por: Hwang, Inah, et al.
Publicado: (2012)

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009)

Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α
por: Zheng, Zhi, et al.
Publicado: (2010)

Combination Therapies Prevent the Neuropathic, Proinflammatory Characteristics of Bone Marrow in Streptozotocin-Induced Diabetic Rats
por: Dominguez, James M., et al.
Publicado: (2015)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012)

Semaphorin3a Promotes Advanced Diabetic Nephropathy
por: Aggarwal, Pardeep K., et al.
Publicado: (2015)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2012)

Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
por: Terami, Naoto, et al.
Publicado: (2014)

Rap1 Ameliorates Renal Tubular Injury in Diabetic Nephropathy
por: Xiao, Li, et al.
Publicado: (2014)

Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
por: Giacco, Ferdinando, et al.
Publicado: (2014)

Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
por: Wang, Xin, et al.
Publicado: (2017)

Intracavernous Delivery of a Designed Angiopoietin-1 Variant Rescues Erectile Function by Enhancing Endothelial Regeneration in the Streptozotocin-Induced Diabetic Mouse
por: Jin, Hai-Rong, et al.
Publicado: (2011)

Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin: A Possible Role of HIF-1α Expression and Oxygen Metabolism
por: Takiyama, Yumi, et al.
Publicado: (2011)

Protein Kinase C-δ Mediates Neuronal Apoptosis in the Retinas of Diabetic Rats via the Akt Signaling Pathway
por: Kim, Young-Hee, et al.
Publicado: (2008)

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2011)

High Glucose Increases Metallothionein Expression in Renal Proximal Tubular Epithelial Cells
por: Ogawa, Daisuke, et al.
Publicado: (2011)

Podocyte-Specific GLUT4-Deficient Mice Have Fewer and Larger Podocytes and Are Protected From Diabetic Nephropathy
por: Guzman, Johanna, et al.
Publicado: (2014)

Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
por: Fan, Ying, et al.
Publicado: (2019)

Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
por: Nakamura, Akihiko, et al.
Publicado: (2012)

Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease
por: Yamanouchi, Masayuki, et al.
Publicado: (2021)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose‐induced oxidative stress in type 1 diabetic mice
por: Hatanaka, Takashi, et al.
Publicado: (2016)

Cadmium Toxicity Is Regulated by Peroxisome Proliferator-Activated Receptor δ in Human Proximal Tubular Cells
por: Mori, Chikage, et al.
Publicado: (2022)

Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines
por: Ogawa, Daisuke, et al.
Publicado: (2014)

Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice
por: Seo, Eoi Jong, et al.
Publicado: (2020)

Patrolling Monocytes Are Recruited and Activated by Diabetes to Protect Retinal Microvessels
por: Tecilazich, Francesco, et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

The Role of Prostaglandins in Disrupted Gastric Motor Activity Associated With Type 2 Diabetes
por: Blair, Peter J., et al.
Publicado: (2019)

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
por: Dasu, Mohan R., et al.
Publicado: (2008)

AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1
por: He, Chaoyong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c8ctvglkiee183rin6vcfd06cl